Taiwan firm to seek FDA new drug approval for enterovirus vaccine

Medigen Vaccine Biologics Corp. said Sunday it will soon apply to the Food and Drug Administration in Taiwan and other countries for new drug approval for its enterovirus 71 (EV71) vaccine, as it has successfully completed its Phase III clinical trials.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)